DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET

Detalhes bibliográficos
Autor(a) principal: Bianchi, Márcia
Data de Publicação: 2014
Outros Autores: Lemmertz, Caroline, Raimundini, Simone Leticia, Vendruscolo, Maria Ivanice
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Ambiente Contábil
Texto Completo: https://periodicos.ufrn.br/ambiente/article/view/5332
Resumo: Derivative minimize the risks of companies operating with foreign currencies and future sales. The use of these financial instruments is increasing through many Brazilian companies that don´t evidence for the lack of effective regulation. The publicly traded companies must show in the notes the risks involved in the operations, the market value and the criteria and assumptions to determine this value of financial instruments and the policies of operation and control of operations. Therefore, the goals of this study is to investigate how is the disclosure of derivatives in the financial statements. It has been done a descriptive research, analyzing the five Brazilian companies in the healthcare sector of the BM&FBovespa, from 2008 to 2012. Was observed that only two companies showed the use of derivatives in all the years analyzed and presented correctly the data sensitivity analysis and risk evaluation. The types of derivatives used by surveyed companies were: forward exchange, currency swap and call option agreement. All companies use derivatives only for hedging purposes. It is noteworthy also that none of the companies surveyed presents quantitative information of its derivatives in the notes in the form of the table contained in Instruction CVM 475 (2008b). From the data analysis, it can be inferred that firms do not fully follow applicable accounting standards, not performing sensitivity analyzes in all years, assessment and measurement of risks in all cases, and not showing adequate and sufficiently derivatives in the notes.Keywords: Derivatives. Disclosure. Branch Health BM&FBovespa. Corporate Accounting. International Accounting Standards.
id UFRN-3_94bddb41266bcfac8164cb87fb7c739d
oai_identifier_str oai:periodicos.ufrn.br:article/5332
network_acronym_str UFRN-3
network_name_str Revista Ambiente Contábil
repository_id_str
spelling DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKETDIVULGACIÓN DE DERIVADOS EN DEMONSTRACIONES FINANCIERAS DE EMPRESAS BRASILEÑAS EN LA ÁREA DE SALUDEVIDENCIAÇÃO DOS DERIVATIVOS NAS DEMONSTRAÇÕES CONTÁBEIS DE EMPRESAS BRASILEIRAS NA ÁREA DA SAÚDEDerivative minimize the risks of companies operating with foreign currencies and future sales. The use of these financial instruments is increasing through many Brazilian companies that don´t evidence for the lack of effective regulation. The publicly traded companies must show in the notes the risks involved in the operations, the market value and the criteria and assumptions to determine this value of financial instruments and the policies of operation and control of operations. Therefore, the goals of this study is to investigate how is the disclosure of derivatives in the financial statements. It has been done a descriptive research, analyzing the five Brazilian companies in the healthcare sector of the BM&FBovespa, from 2008 to 2012. Was observed that only two companies showed the use of derivatives in all the years analyzed and presented correctly the data sensitivity analysis and risk evaluation. The types of derivatives used by surveyed companies were: forward exchange, currency swap and call option agreement. All companies use derivatives only for hedging purposes. It is noteworthy also that none of the companies surveyed presents quantitative information of its derivatives in the notes in the form of the table contained in Instruction CVM 475 (2008b). From the data analysis, it can be inferred that firms do not fully follow applicable accounting standards, not performing sensitivity analyzes in all years, assessment and measurement of risks in all cases, and not showing adequate and sufficiently derivatives in the notes.Keywords: Derivatives. Disclosure. Branch Health BM&FBovespa. Corporate Accounting. International Accounting Standards.Los derivados reducen los riesgos de empresas que operan con monedas extranjeras y las ventas futuras. El uso de estos instrumentos financieros es cada vez mayor, y muchas empresas brasileñas no les dejan evidentes por falta de una regulamentación eficaz. Las empresas de capital abierto deben dejar evidentes en notas explicativas los riesgos inherentes a las operaciones, el valor de mercado y los critérios y supuestos para la determinación de este valor de los instrumentos financieros, y las políticas de actuación y control de las operaciones. Por lo tanto, el objetivo de este estudo es verificar como se dá la evidenciación en las demonstraciones financieras. Se realizó una pesquisa descriptiva, documental, com enfoque cualitativo, con  análisis de las cinco empresas del segmento de servicios médicos y hospitalários, análisis y diagnóstico, en el período de 2008 hasta 2012. Fué visto que apenas dos empresas declaran el uso de derivados en todos los años analisados y apresentan de forma correcta los dados de análisis de sensibilidad y de evaluación de riesgos. La clasificación de derivados utilizados por las empresas pesquisadas fueron: contratos de cambio a termo, swap de monedas y opciones de call. Todas las empresas utilizan derivados con la finalidad de protección. Es de destacar también que de las empresas pesquisadas ninguna presenta las informaciones cuantitativas de sus derivados en las notas explicativas en la forma de tablas que contiene la Instrucción Normativa nº 475 de la CVM (2008b). A partir del análisis de dados, se puede inferir que todavia las empresas no siguen plenamente las normas de contabilidad aplicables, y no realizan análisis de sensibilidad todos los años, evaluación y medición de los riesgos en todos los casos, y también no evidencian adecuadamente y suficientemente los derivados en las notas explicativas.Palabras-clave: Derivados. Evidenciación. Ramo Salud BM&FBovespa. Contabilidad Corporativa. Normas Internacionales de Contabilidad. Os derivativos minimizam os riscos das empresas que operam com moedas estrangeiras e vendas futuras. O uso destes instrumentos financeiros é crescente, sendo que muitas empresas brasileiras deixam de evidenciá-los pela falta de uma regulamentação eficaz. As empresas de capital aberto devem evidenciar em notas explicativas os riscos envolvidos nas operações, o valor de mercado e os critérios e premissas para a determinação deste valor dos instrumentos financeiros, e as políticas de atuação e controle das operações. Assim sendo, o objetivo deste estudo analisar a evidenciação de instrumentos financeiros derivativos nas demonstrações contábeis das empresas brasileiras, que constam na classificação da BM&FBovespa como pertencentes ao setor de Saúde. Foi realizada uma pesquisa descritiva, documental, com abordagem qualitativa, analisando as cinco empresas classificadas no segmento de serviços médico-hospitalares, análises e diagnóstico, no período de 2008 a2012. Observou-se que apenas duas empresas declaram o uso de derivativos em todos os anos analisados e apresentam corretamente os dados de análise de sensibilidade e de avaliação de riscos. Os tipos de derivativos utilizados pelas empresas pesquisadas foram: contrato de câmbio a termo, swap de moeda e opções de call. Todas as empresas utilizam derivativos apenas com a finalidade de proteção. Ressalta-se, ainda, que das empresas pesquisadas nenhuma apresenta as informações quantitativas de seus derivativos nas notas explicativas na forma da tabela contida na Instrução Normativa no 475 da CVM (2008b). A partir da análise dos dados, pode-se inferir que as empresas ainda não seguem plenamente as normas contábeis vigentes, não realizando análises de sensibilidade em todos os anos, avaliação e mensuração dos riscos em todos os casos, além de não evidenciarem adequada e suficientemente os derivativos nas notas explicativas.Palavras-chave: Derivativos. Evidenciação. Ramo Saúde BM&FBovespa. Contabilidade Societária. Normas Internacionais de Contabilidade.Portal de Periódicos Eletrônicos da UFRN2014-07-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/mswordhttps://periodicos.ufrn.br/ambiente/article/view/5332REVISTA AMBIENTE CONTÁBIL - Universidade Federal do Rio Grande do Norte; Vol. 6 No. 2 (2014): Jul./Dez.; 282-301REVISTA AMBIENTE CONTÁBIL - Universidade Federal do Rio Grande do Norte; Vol. 6 Núm. 2 (2014): Jul./Dez.; 282-301REVISTA AMBIENTE CONTÁBIL - Universidade Federal do Rio Grande do Norte - ISSN 2176-9036; v. 6 n. 2 (2014): Jul./Dez.; 282-3012176-9036reponame:Revista Ambiente Contábilinstname:Universidade Federal do Rio Grande do Norte (UFRN)instacron:UFRNporhttps://periodicos.ufrn.br/ambiente/article/view/5332/4510https://periodicos.ufrn.br/ambiente/article/view/5332/10225Copyright (c) 2016 REVISTA AMBIENTE CONTÁBIL - Universidade Federal do Rio Grande do Norte - ISSN 2176-9036info:eu-repo/semantics/openAccessBianchi, MárciaLemmertz, CarolineRaimundini, Simone LeticiaVendruscolo, Maria Ivanice2019-10-09T22:32:46Zoai:periodicos.ufrn.br:article/5332Revistahttps://periodicos.ufrn.br/ambientePUBhttps://periodicos.ufrn.br/ambiente/oai||prof.mauriciocsilva@gmail.com2176-90362176-9036opendoar:2019-10-09T22:32:46Revista Ambiente Contábil - Universidade Federal do Rio Grande do Norte (UFRN)false
dc.title.none.fl_str_mv DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET
DIVULGACIÓN DE DERIVADOS EN DEMONSTRACIONES FINANCIERAS DE EMPRESAS BRASILEÑAS EN LA ÁREA DE SALUD
EVIDENCIAÇÃO DOS DERIVATIVOS NAS DEMONSTRAÇÕES CONTÁBEIS DE EMPRESAS BRASILEIRAS NA ÁREA DA SAÚDE
title DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET
spellingShingle DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET
Bianchi, Márcia
title_short DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET
title_full DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET
title_fullStr DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET
title_full_unstemmed DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET
title_sort DISCLOSURE OF DERIVATIVE FINANCIAL STATEMENTS OF THE BRAZILIAN COMPANIES IN THE HEALTH MARKET
author Bianchi, Márcia
author_facet Bianchi, Márcia
Lemmertz, Caroline
Raimundini, Simone Leticia
Vendruscolo, Maria Ivanice
author_role author
author2 Lemmertz, Caroline
Raimundini, Simone Leticia
Vendruscolo, Maria Ivanice
author2_role author
author
author
dc.contributor.author.fl_str_mv Bianchi, Márcia
Lemmertz, Caroline
Raimundini, Simone Leticia
Vendruscolo, Maria Ivanice
description Derivative minimize the risks of companies operating with foreign currencies and future sales. The use of these financial instruments is increasing through many Brazilian companies that don´t evidence for the lack of effective regulation. The publicly traded companies must show in the notes the risks involved in the operations, the market value and the criteria and assumptions to determine this value of financial instruments and the policies of operation and control of operations. Therefore, the goals of this study is to investigate how is the disclosure of derivatives in the financial statements. It has been done a descriptive research, analyzing the five Brazilian companies in the healthcare sector of the BM&FBovespa, from 2008 to 2012. Was observed that only two companies showed the use of derivatives in all the years analyzed and presented correctly the data sensitivity analysis and risk evaluation. The types of derivatives used by surveyed companies were: forward exchange, currency swap and call option agreement. All companies use derivatives only for hedging purposes. It is noteworthy also that none of the companies surveyed presents quantitative information of its derivatives in the notes in the form of the table contained in Instruction CVM 475 (2008b). From the data analysis, it can be inferred that firms do not fully follow applicable accounting standards, not performing sensitivity analyzes in all years, assessment and measurement of risks in all cases, and not showing adequate and sufficiently derivatives in the notes.Keywords: Derivatives. Disclosure. Branch Health BM&FBovespa. Corporate Accounting. International Accounting Standards.
publishDate 2014
dc.date.none.fl_str_mv 2014-07-29
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.ufrn.br/ambiente/article/view/5332
url https://periodicos.ufrn.br/ambiente/article/view/5332
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://periodicos.ufrn.br/ambiente/article/view/5332/4510
https://periodicos.ufrn.br/ambiente/article/view/5332/10225
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/msword
dc.publisher.none.fl_str_mv Portal de Periódicos Eletrônicos da UFRN
publisher.none.fl_str_mv Portal de Periódicos Eletrônicos da UFRN
dc.source.none.fl_str_mv REVISTA AMBIENTE CONTÁBIL - Universidade Federal do Rio Grande do Norte; Vol. 6 No. 2 (2014): Jul./Dez.; 282-301
REVISTA AMBIENTE CONTÁBIL - Universidade Federal do Rio Grande do Norte; Vol. 6 Núm. 2 (2014): Jul./Dez.; 282-301
REVISTA AMBIENTE CONTÁBIL - Universidade Federal do Rio Grande do Norte - ISSN 2176-9036; v. 6 n. 2 (2014): Jul./Dez.; 282-301
2176-9036
reponame:Revista Ambiente Contábil
instname:Universidade Federal do Rio Grande do Norte (UFRN)
instacron:UFRN
instname_str Universidade Federal do Rio Grande do Norte (UFRN)
instacron_str UFRN
institution UFRN
reponame_str Revista Ambiente Contábil
collection Revista Ambiente Contábil
repository.name.fl_str_mv Revista Ambiente Contábil - Universidade Federal do Rio Grande do Norte (UFRN)
repository.mail.fl_str_mv ||prof.mauriciocsilva@gmail.com
_version_ 1799770187294048256

Registros relacionados